Melanoma gp100 antibody
Quick Overview for Melanoma gp100 antibody (ABIN3024239)
Target
See all Melanoma gp100 (PMEL) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
No Cross-Reactivity
- Rat (Rattus)
-
Purification
- Protein G affinity chromatography
-
Immunogen
- Membranes from a human melanoma metastasis were used as the immunogen for this anti-gp100 antibody.
-
Isotype
- IgG2b kappa
-
-
-
-
Application Notes
-
The optimal dilution of the anti-gp100 antibody for each application should be determined by the researcher.
1. Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes.\. Flow Cytometry: 0.5-1 μg/million cells in 0.1ml,Immunofluorescence: 1-2 μg/mL,Immunohistochemistry (FFPE): 1-2 μg/mL for 30 minutes at RT (1)
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the anti-gp100 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
-
-
- Melanoma gp100 (PMEL) (Premelanosome Protein (PMEL))
-
Alternative Name
- Gp100
-
Background
- By immunohistochemistry, it specifically recognizes a protein in melanocytes and melanomas. This mAb reacts with junctional and blue nevus cells and variably with fetal and neonatal melanocytes. Intradermal nevi, normal adult melanocytes, and non-melanocytic cells are negative. It does not stain tumor cells of epithelial, lymphoid, glial, or mesenchymal origin.This Mab labels formalin-fixed, paraffin-embedded melanomas and other tumors showing melanocytic differentiation.
Target
-